FDA Logo links to FDA home page
U.S. Food and Drug Administration
  HHS Logo links to Department of Health and Human Services website
 MedWatch logoThe FDA Safety Information and Adverse Event Reporting Program


line line line line line

Stay Informed
Subscribe to receive safety alerts
Get e-mail updates By email | MedWatch RSS [XML] Feed By RSS

What's New

Tarceva (erlotinib) - Dear Healthcare Professional letter issued to warn about GI perforation, exfoliative skin conditions and corneal perforation/ulceration.
(Posted 05/08/2008)

Biosite brand Triage Cardiac Panel - Use of affected lots of the Triage Cardiac Panel may lead to false negative results, possibly resulting in missed or incorrect diagnosis.
(Posted 05/08/2008)

Testosterone gel products (AndroGel 1% and Testim 1%) - Boxed warning required to inform users of risk of unintended secondary exposure of children to testosterone.
(Posted 05/07/2009)

Antiepileptic Drugs - FDA approved updated labeling to warn about an increased risk of suicidal thoughts and behaviors.
(Posted 05/05/2009)

May 2009 Patient Safety News - Video news show for healthcare professionals, covering safety alerts, recalls, product approvals, and important tips on protecting patients.
(Posted 05/05/2009)

Hydroxycut Products - Dietary supplements are associated with serious liver injury, including liver failure, seizures, cardiovascular disorders, and rhabdomyolysis.
(Posted 05/01/2009)

Disetronic Medical Systems Inc. ACCU-CHEK Spirit insulin pump - A defect in the “up” and/or “down” buttons, which would result in users being unable to change any programmed setting on the pump.
(Posted 05/01/2009)

Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B) - Strengthened warnings in product labeling and boxed warning regarding the risk of adverse events when the effects of the toxin spread beyond the site where it was injected.
(Posted 04/30/2009)

Libimax - Recall of dietary supplement due to undeclared drug tadalafil, which may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels.
(Posted 04/29/2009)

Personal Care Non-Acetone Nail Polish Remover - Nationwide recall issued because of the potential for the product to cause chemical burns to the fingers of users.
(Posted 04/29/2009)

Welcome to MedWatch, your Internet gateway for timely safety information on drugs and other medical products regulated by the U.S. Food and Drug Administration.

Safety Information

Safety Information

Medical Product
Reporting

Medical Product Reporting

Educational Resources

Safety Information Resources for Health Professionals

Learn about medical product safety information available from FDA.

Video, approximately 11 minutes

Windows: 300k | 150k
Real:         300k | 150k

Choose 150k bit rate videos for slower internet connections.

Video screenshot featuring FDA Director Dr. Janet Woodcock

"Busy healthcare professionals need the best safety information at the right time to help manage their patients' care."

Dr. Janet Woodcock, FDA


FDA MedWatch and Patient Safety

A self-learning tutorial covering the MedWatch program goals of broadcasting safety information and encouraging adverse event reporting. MedWatch tutorial screenshots

MedWatch Widget - Add links to important MedWatch content into your own Web pages

 
horizonal rule